A Study of LY3502970 in Healthy Male Participants

NCT04680767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3502970
DRUG: [¹⁴C]-LY3502970

Sponsor

Eli Lilly and Company